Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.Lepr Rev. 2005 Jun; 76(2):167-9.LR
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
16038251
Citation
Goulart, Isabela M B., et al. "Aplastic Anaemia Associated With Multidrug Therapy (dapsone, Rifampicin and Clofazimine) in a Patient With Lepromatous Leprosy." Leprosy Review, vol. 76, no. 2, 2005, pp. 167-9.
Goulart IM, Reis AC, De Rezende TM, et al. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy. Lepr Rev. 2005;76(2):167-9.
Goulart, I. M., Reis, A. C., De Rezende, T. M., Borges, A. S., Ferreira, M. S., & Nishioka, S. A. (2005). Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy. Leprosy Review, 76(2), 167-9.
Goulart IM, et al. Aplastic Anaemia Associated With Multidrug Therapy (dapsone, Rifampicin and Clofazimine) in a Patient With Lepromatous Leprosy. Lepr Rev. 2005;76(2):167-9. PubMed PMID: 16038251.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
AU - Goulart,Isabela M B,
AU - Reis,Ana Cláudia S,
AU - De Rezende,Tatiana M N,
AU - Borges,Aércio S,
AU - Ferreira,Marcelo S,
AU - Nishioka,Sérgio A,
PY - 2005/7/26/pubmed
PY - 2005/9/1/medline
PY - 2005/7/26/entrez
SP - 167
EP - 9
JF - Leprosy review
JO - Lepr Rev
VL - 76
IS - 2
SN - 0305-7518
UR - https://www.unboundmedicine.com/medline/citation/16038251/Aplastic_anaemia_associated_with_multidrug_therapy__dapsone_rifampicin_and_clofazimine__in_a_patient_with_lepromatous_leprosy_
L2 - https://medlineplus.gov/aplasticanemia.html
DB - PRIME
DP - Unbound Medicine
ER -